This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2016 US Therapeutic Drug Monitoring (TDM) Market is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 249 pages and 19 tables
SIMILAR MARKET STUDIES
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed ...
March 2017 | $0 | View Details >>
2016 Emerging Opportunities in the US Immunoprotein Diagnostic Testing Market: Hospitals, Commercial Labs, Physician Offices -Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
This new 236-page report from VPGMarketResearch.com provides analysis of the US immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by market segment for the follow assays:C3C4Free Light ChainsHaptoglobinIgAIgE Specific IgE TotalIgGIgMImmunofixationPrealbuminProtein ElectrophoresisDuring ...
October 2015 | $2200 | View Details >>
The report provides a worldwide strategic overview of the diagnostic imaging market, including Estimates of the market size and growth. Sales forecasts by geographic region and modality.
January 2015 | $0 | View Details >>
Complete report $6,800. DataPack (test volumes, sales forecasts, supplier shares) $3,450.“2015-2019 Italy Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diagnostics markets; reviews current and emerging tests; analyzes ...
September 2015 | $4350 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research